Symbol: |
GPHN
|
Description: |
gephyrin [Source:HGNC Symbol;Acc:15465]
|
Location: |
Chr14:66974125-67648520[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:115
Gene |
Compound |
Gen_sig |
Exp_pattern |
GPHN |
CHAETOGLOBOSIN A |
0.023 |
Up |
GPHN |
NSC 49789 |
0.032 |
Up |
GPHN |
NSC 57958 |
0.012 |
Up |
GPHN |
NSC 58903 |
0.017 |
Up |
GPHN |
RAPAMYCIN PRODRUG |
0.012 |
Up |
GPHN |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.021 |
Up |
GPHN |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.039 |
Up |
GPHN |
4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- |
0.042 |
Up |
GPHN |
NSC 62349 |
0.047 |
Up |
GPHN |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.028 |
Up |
GPHN |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.028 |
Up |
GPHN |
Naphthalene-1,2-dione, 1,2-dihydro- 4-[(2-phenylethyl)amino]- |
0.002 |
Down |
GPHN |
Ethanedioic acid, mono(6-nitrobenzothiazol-2-yl)amide, mono[[2-(acetylhydrazino)-4-methylthiazol-5-yl]carbonyl] hydrazide |
0.024 |
Up |
GPHN |
NSC 643836 |
0.035 |
Up |
GPHN |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.048 |
Up |
Expression pattern: Sensitivity / Resistance
Total:8 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:19
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:25
Total:2 Current:1
[First] [Prev]  Next Last 
|